EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
11.78
-0.48 (-3.92%)
Jun 5, 2026, 4:00 PM EDT - Market closed

EyePoint Revenue

EyePoint had revenue of $696.00K in the quarter ending March 31, 2026, a decrease of -97.15%. This brings the company's revenue in the last twelve months to $7.62M, down -86.41% year-over-year. In the year 2025, EyePoint had annual revenue of $31.37M, down -27.50%.

Revenue (ttm)
$7.62M
Revenue Growth
-86.41%
P/S Ratio
129.72
Revenue / Employee
$35,579
Employees
214
Market Cap
987.65M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202531.37M-11.90M-27.50%
Dec 31, 202443.27M-2.75M-5.97%
Dec 31, 202346.02M4.61M11.14%
Dec 31, 202241.40M4.47M12.09%
Dec 31, 202136.94M2.50M7.27%
Dec 31, 202034.44M14.07M69.10%
Dec 31, 201920.37M15.79M345.53%
Dec 31, 20184.57M1.61M54.37%
Jun 30, 20182.96M-4.58M-60.72%
Jun 30, 20177.54M5.92M365.37%
Jun 30, 20161.62M-24.95M-93.90%
Jun 30, 201526.57M23.09M664.90%
Jun 30, 20143.47M1.33M62.06%
Jun 30, 20132.14M-1.38M-39.22%
Jun 30, 20123.53M-1.44M-28.98%
Jun 30, 20114.97M-18.09M-78.46%
Jun 30, 201023.05M10.89M89.55%
Jun 30, 200912.16M8.69M249.88%
Jun 30, 20083.48M1.69M94.73%
Jun 30, 20071.79M749.00K72.30%
Jun 30, 20061.04M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pharming Group369.49M
MannKind360.78M
Xencor97.36M
Wave Life Sciences71.80M
Zenas BioPharma10.00M
Aktis Oncology8.28M
DBV Technologies5.74M
Absci1.84M
Revenue Rankings